In addition, the in vitro antiangiogenic effects of somatostatin and its analogues have been previously shown by studies on melanoma cells, which expressed one or more SSTR and were treated by using somatostatin or SSAs [20], [50]. The gene discussed is SST; the disease is melanoma.